14th European Congress of Clinical Microbiology and Infectious ...

Meeting
Hall IV
Scientific Programme Tuesday, May 4, 2004
The international dimension of
epidemiological typing
Chairpersons: Alex van Belkum (Leiden, NL)
Marek Gniadkowski (Warsaw, PL)
S337 The easy visualisation of clones from
10:00 multilocus sequence typing data
Ed Feil (Bath, UK)
S338 Genetic portraits of methicillin-resistant
10:24 Staphylococcus aureus clones in hospitals
and in the community
Marta Aires de Sousa (Oeiras, P)
S339 Review of MDR tuberculosis in Russia
10:48 Serguei Popov (Moscow, RUS)
S340 Dissemination of antimicrobial resistance in
11:12 the nosocomial environment
Marek Gniadkowski (Warsaw, PL)
S341 Microbial surveillance of diphtheria across
11:36 Europe
Androulla Efstratiou (London, UK)
South
Hall
Official symposium arranged with the European
Study Group on Epidemiological Markers (ESGEM)
Auditing antimicrobial prescriptions in Europe
Chairpersons: Ian Gould (Aberdeen, UK)
Vlastimil Jindrak (Prague, CZ)
S342 Audit Project Odense for General Practice
10:00 Kirsten Schaefer (Roskilde, DK)
S343 Antibiotic prescribing in the primary
10:30 paediatric care in central eastern Europe –
common history with different approaches
Vlastimil Jindrak (Prague, CZ)
S344 Antibiotic prophylaxis in surgery:
11:00 the Dutch experience
Inge Gyssens (Rotterdam, NL)
S345 Antibiotic prescribing practices and policies in
11:30 intensive care units
Dominique L. Monnet (Copenhagen, DK)
Official symposium arranged with the European
Study Group on Antibiotic Policies (ESGAP)
page 58 Final Programme
Club A
Oral Sessions
Antibiotic resistance: from ESBL to
fluoroquinolones
Chairpersons: Luisa Peixe (Porto, P)
Johan Maertens (Leuven, B)
O346 EARSS report on increasing fluoroquinolone
10:00 resistance among Escherichia coli in Europe
H. Grundmann, P. Schrijnemakers, N. Bruinsma,
E. Tiemersma, J. Monen, J.E. Degener,
G. Cornaglia and EARSS participants
O347 First detection of the transferable quinolone
10:12 resistance determinant in clinical Providencia
stuartii strains in Egypt
I. Wiegand, N. Khalaf, M.H.M. Al-Agamy,
B. Wiedemann (Bonn, D; Cairo, EGY)
O348 Fluoroquinolone consumption and
10:24 fluoroquinolone resistance in haematologyoncology
patients – Ecological analysis in two
university hospitals, 1999–2002
W.V. Kern, K. de With, C. Gonnermann, E. Strehl,
M. Steib-Bauert, S. Reuter, H. Bertz, U. Frank,
H. von Baum (Freiburg, Ulm, D)
O349 Genetic analysis of emerging fluoroquinolone-
10:36 resistant Escherichia coli in Indonesia
K. Kuntaman, E.S. Lestari, J. Severin,
N.M. Mertaniasih, M. Purwanta, A. van Belkum,
H.A. Verbrugh on behalf of the Antimicrobial
Resistance in Indonesia (AMRIN) study group
O350 Outpatient use of fluoroquinolones in Europe
10:48 with focus on respiratory tract infections
H. Goossens, K. Dirven, M. Ferech
the ESAC Project Group
O351 Extended-spectrum beta-lactamases from
11:00 the community and hospital environments
in Portugal: dissemination of TEM-24
E. aerogenes European epidemic clone and
emergence of CTX-M enzymes
E. Machado, R. Cantón, A. Rollán, J.C. Sousa,
F. Baquero, T.M. Coque, L. Peixe
(Porto, P; Madrid, E)
O352 Isolation of extended-spectrum beta-
11:12 lactamase producing Enterobacteriaceae from
community-based patients in the United
Kingdom
F. M'Zali, J. Dave, S. Ager, M. Denton
(Leeds, UK)
O353 Characterisation of a new integron carrying a
11:24 metallo-beta-lactamase and a carbenicillinase
from Pseudomonas aeruginosa
S.M. Quinteira, J.C. Sousa, L. Peixe
(VN Famalicão, Porto, P)